Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to $2.9 million.

  • Anaptysbio's Interest & Investment Income fell 4507.89% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year decrease of 1626.4%. This contributed to the annual value of $19.8 million for FY2024, which is 488.0% up from last year.
  • Per Anaptysbio's latest filing, its Interest & Investment Income stood at $2.9 million for Q3 2025, which was down 4507.89% from $3.7 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Interest & Investment Income peaked at $5.3 million during Q3 2024, and registered a low of $64000.0 during Q3 2021.
  • For the 5-year period, Anaptysbio's Interest & Investment Income averaged around $3.0 million, with its median value being $3.8 million (2022).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 9019.79% in 2021, then surged by 554558.82% in 2022.
  • Anaptysbio's Interest & Investment Income (Quarter) stood at $68000.0 in 2021, then skyrocketed by 5545.59% to $3.8 million in 2022, then grew by 27.12% to $4.9 million in 2023, then rose by 7.85% to $5.3 million in 2024, then plummeted by 44.44% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $3.7 million for Q2 2025, and $4.4 million during Q1 2025.